Company Analysis Emergent BioSolutions Inc.
1. Summary
Advantages
- The stock's return over the last year (118.48%) is higher than the sector average (-15.35%).
Disadvantages
- Price (7.21 $) is higher than fair price (6.12 $)
- Dividends (0%) are below the sector average (1.3%).
- Current debt level 47.07% has increased over 5 years from 34.82%.
- The company's current efficiency (ROE=-117.13%) is lower than the sector average (ROE=-82.41%)
Similar companies
2. Share price and performance
2.1. Share price
2.2. News
2.3. Market efficiency
| Emergent BioSolutions Inc. | Healthcare | Index | |
|---|---|---|---|
| 7 days | -9.5% | -13.8% | -1.2% |
| 90 days | -28.7% | -16.1% | -1.6% |
| 1 year | 118.5% | -15.3% | 16.9% |
EBS vs Sector: Emergent BioSolutions Inc. has outperformed the "Healthcare" sector by 133.83% over the past year.
EBS vs Market: Emergent BioSolutions Inc. has outperformed the market by 101.58% over the past year.
Stable price: EBS is not significantly more volatile than the rest of the market on "New York Stock Exchange" over the last 3 months, with typical variations of +/- 5% per week.
Long period: EBS with weekly volatility of 2.28% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (7.21 $) is higher than the fair price (6.12 $).
Price is higher than fair: The current price (7.21 $) is 15.1% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (18.1) is lower than that of the sector as a whole (114.26).
P/E vs Market: The company's P/E (18.1) is lower than that of the market as a whole (73.51).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (0.1956) is lower than that of the sector as a whole (9.02).
P/BV vs Market: The company's P/BV (0.1956) is lower than that of the market as a whole (22.32).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (0.121) is lower than that of the sector as a whole (4.1).
P/S vs Market: The company's P/S indicator (0.121) is lower than that of the market as a whole (15.92).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (-20.81) is lower than that of the sector as a whole (17.72).
EV/Ebitda vs Market: The company's EV/Ebitda (-20.81) is lower than that of the market as a whole (22.62).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -69.85% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-69.85%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-50.52%).
5.4. ROE
ROE vs Sector: The company's ROE (-117.13%) is lower than that of the sector as a whole (-82.41%).
ROE vs Market: The company's ROE (-117.13%) is lower than that of the market as a whole (25.01%).
5.5. ROA
ROA vs Sector: The company's ROA (-41.45%) is lower than that of the sector as a whole (6.75%).
ROA vs Market: The company's ROA (-41.45%) is lower than that of the market as a whole (6.62%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (7.57%) is lower than that of the sector as a whole (15.68%).
ROIC vs Market: The company's ROIC (7.57%) is lower than that of the market as a whole (9.31%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 0% is below the average for the sector '1.3%.
7.2. Stability and increase in payments
Unstable dividends: The company's dividend yield 0% has not been consistently paid over the past 7 years, DSI=0.5.
Weak dividend growth: The company's dividend yield 0% has been growing weakly or stagnant over the past 5 years. Growth over only 1 year.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
